Yes, and I'll build on that a little bit from -- if you look at Darling, one of the competitive advantages and disadvantages we have is we're public. And we do segment and share and ultimately, the main raw material in our specialty collagen business is bovine hide Grass Fed bovine hide. The transparency of the earnings power that we have ultimately, no different than Diamond Green Diesel in the sense of how successful we've been there, attracted competition. It's somewhat of a micro market around the world, the numbers range from 600,000 to 700,000 tons globally. And ultimately, when you added the 15,000 or 20,000 ton plant, it takes a year or so to place that volume. And that's what's happened in Brazil with a couple of factories. They're looking for customers today. Ultimately, how do you get a customer, you buy a customer. And so that's the driver of the decline in sales value. But ultimately, it also -- it's a spread management business for us on the commodity gelatin business and then ultimately in the collagen business. It is a very specialty ingredient. So our margins have pretty much maintained what we've been able to hold. The outlook for 2025 is exciting for us. I mean, obviously, next week, we talked about being out to launch Nextida, it is available. There are a number of customers there and how quickly that ramps up. And then we've got three or four other products behind it now that will be coming on over the course of the next year, two years, three years. So we see ourselves differentiating ourselves once again from everybody else in that business, but ultimately, it's a great business, and we're -- and also keep in mind when you look at that business, remember, 80% of that business is really kind of feed and fat. And so ultimately, if we get any fat price improvement, that ultimately translates back into that business to on top of the specialty ingredient being generated. So that looks pretty strong for 2025 here.